Jiangxi cancer hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Colorectal cancer1 trial
• Head and neck cancer1 trial

Phase

• Phase 1/21 trial

Status

• Recruiting2 trials

Lead sponsor

• Betta Pharmaceuticals Co., Ltd.1 trial
• Daiichi Sankyo1 trial

Running trials

• Recruiting

  Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)

  NCT06809764· Daiichi Sankyo· Source

  Contact: Principal Investigator

• Recruiting

  Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors

  NCT04930432· Phase 1/2· Betta Pharmaceuticals Co., Ltd.· Source

  Contact: Wanlin Chen, Master

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Colorectal cancer1 recruiting
• Head and neck cancer1 recruiting